Clinical Trials
378 trialsOPAL
iOMEDICO AG
MoMMent
Janssen Pharmaceutica N.V., Belgium
REALiTEC/TAL
Janssen-Cilag Ltd.
QOLIBRI
Janssen Cilag S.A.S.
LEPIDOPTERA
Janssen Research & Development, LLC
Nova-sTAR
Janssen Research & Development, LLC
OBSAPA
Janssen Cilag S.A.S.
REALITY-RO
Janssen Research & Development, LLC
JADE
iOMEDICO AG
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Hoffmann-La Roche
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
HistoSonics, Inc.
GlofitReal
Hoffmann-La Roche
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
argenx
BASECAMP-1
A2 Biotherapeutics Inc.
EPIC
AstraZeneca
EXCEED
AstraZeneca
BARHYSTER
Aesculap AG
PROWESs
AstraZeneca
IREN
AstraZeneca
Spectral Precise Image Study for Brain Tumors
Philips Clinical & Medical Affairs Global
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea
Novartis
Real-World Treatment Study of Koselugo (Selumetinib)
AstraZeneca
Post Marketing Study on Pluvicto in Korea
Novartis
Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Novartis
UmbREALung
AstraZeneca
Real World Multicenter National Study to Evaluate the Effectiveness and Safety of Biosimilar Bevacizumab Elovie
Libbs Farmacêutica LTDA
CAROLEEN
Novartis
GYNGHER
AstraZeneca
DP-04
AstraZeneca
Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
Ipsen
BETTER-UAE
Merit Medical Systems, Inc.
Pangeia-2
AstraZeneca
ENAiBLE
Photocure
23146
Bayer
INFO SPINE
Metrosan End. ve Elk. Mek. Cihazlar ve Tibbi Malz. San. Tic. Ltd. Co.
RIVERS
AstraZeneca
OLIVIA
AstraZeneca
BV-MAZOVIA
Takeda
OSIREAL
AstraZeneca
MK-3475-U01
Merck Sharp & Dohme LLC
REBECCA
AstraZeneca
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Hoffmann-La Roche
MONTEROSA
AstraZeneca
SCOUT-1
AstraZeneca
RACE-2L
AstraZeneca
NAUTIC
AstraZeneca
Falcon Real World Evidence Registry
Exact Sciences Corporation
ELEGANCE
Novartis
LUNG-ROLL
AstraZeneca
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Blueprint Medicines Corporation